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Abstract: 
Aims: To assess the feasibility of performing extralevator abdominoperineal excision (ELAPE) after 
neoadjuvant chemoradiation, compare the rates of circumferential resection margin (CRM) 
involvement, intra-operative perforation (IOP) and amount of tissue removed around the muscularis 
propria (MP)/internal sphincter (IS) of the lower rectum in patients with low rectal cancer 
undergoing ELAPE as compared to conventional abdominoperineal excision (CAPE) after NCRT. 
Methods: This was an open-label, parallel arm pilot randomized trial conducted in India. Twenty 
patients were randomised to one of the study arms. The surgical specimens were fixed, serially 
cross-sectioned and photographed. Using specialised morphometry software, the amount of tissue 
resected with each operation was measured.  
Results: There was a non-significant trend towards more intra-operative perforations (30% vs 0%, 
p=0.06) and a higher CRM involvement rate (40% vs 20%, p=0.32) in the CAPE arm. ELAPE removed a 
significantly greater amount of tissue around the IS/MP when compared to CAPE (1911.39 ± 382mm2 
vs 1132.03 ± 371mm2[SD], p<0.001). The mean distance from the IS/MP to the CRM was significantly 
greater in the ELAPE arm in the posterior (28.28 ± 3mm vs 9.63 ± 3mm[SD], p<0.001) and lateral 
(13.69 ± 3mm vs 9.72 ± 3mm[SD], p=0.009) parts of the rectum but not in the anterior part (6.74 ± 
2mm vs 6.10 ± 4mm [SD], p=0.64). The short-term morbidity was not significantly different between 
the two procedures.  
Conclusion: ELAPE removed more tissue in the lower rectum and resulted in a lower rate of IOP and 
CRM involvement when compared to CAPE even after NCRT.  
 
Registered with Clinical Trial Registry of India (CTRI no:2013/05/003661) 
Keywords: abdominoperineal excision, extralevator abdominoperineal excision, circumferential 
resection margin, intra-operative perforation, morbidity 
Presented in the biennial conference of the International Society of University Colorectal Surgeons, 
Mumbai, India, September 2016 and the annual conference of the Indian Association of Surgical 
Gastroenterology, Coimbatore, India, October 2016 
What does this paper add to the literature: This paper shows that extralevator abdominoperineal 
excision removes more tissue around the internal sphincter/muscularis propria of the lower rectum 
than a conventional abdominoperineal excision and thus has the potential to reduce the chances of 
circumferential margin involvement and intra-operative perforations even after neoadjuvant 
chemoradiation. 
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Introduction: 
Abdominoperineal excision (APE) is a commonly performed operation for low rectal cancer in many 
parts of the world in spite of the advancements in neoadjuvant treatments and sphincter preserving 
techniques [1,2]. However, APE is associated with a higher local recurrence rate and poorer survival 
when compared to low anterior resection for higher tumours [3,4,5]. This adverse outcome has been 
attributed to the plane of surgery during conventional APE as practiced nowadays which follows the 
principle of total mesorectal excision and cones down on the rectal tube at the level of the pelvic 
floor in contrast to the original procedure described by Ernest Miles.  This leads to an increased 
incidence of involved circumferential resection margin (CRM) and intra-operative perforation (IOP) 
[6,7]. Therefore, an alternative technique called cylindrical APE or extralevator abdominoperineal 
excision (ELAPE) was proposed [8] which is more similar to the Miles procedure. Earlier studies have 
shown that ELAPE removes more tissue outside the muscularis propria (MP)/ internal sphincter (IS) 
of the lower rectum resulting in a reduced incidence of involved CRM and IOP when compared to a 
conventional APE (CAPE)[9,10,11]. However, these were either non-randomized studies or included 
many patients who did not receive neoadjuvant chemoradiation (NCRT). Locally advanced low rectal 
cancers, especially those needing an APE are considered high risk for recurrence and hence 
neoadjuvant chemoradiation (NCRT) is recommended for these tumours [12]. NCRT is known to 
cause tumour downstaging and a subsequent reduction in the rates of involved CRM [13,14,15]. 
Although logically the group of patients receiving NCRT are those with locally advanced tumors and 
hence would benefit more with a procedure like ELAPE, it is still unclear whether the tumour 
downstaging effect of NCRT will negate the advantages of an ELAPE. The primary objective of this 
study, therefore, was to assess the feasibility of performing ELAPE after NCRT and to compare the 
short-term outcomes of ELAPE and CAPE in patients who have received NCRT. 
Materials and Methods:  
Study design and Patients: 
This was a pilot open-label randomized, parallel arm study conducted between May 2013 and 
December 2015. The primary objective was to study the feasibility of performing ELAPE after NCRT 
and to compare the rates of CRM involvement, IOP, specimen gradings and amount of tissue 
removed around the rectum in patients with low rectal cancer undergoing ELAPE as compared to 
conventional APE. The secondary objective was to compare the intra-operative complications, blood 
loss, operative time and perineal wound complications between the two groups. Since there is a 
wide variation in the rates of CRM involvement and IOP following ELAPE and conventional/standard 
APE in previous studies, most of which were retrospective and in different time periods, we felt the 
need for a pilot study and hence sample size calculation was not attempted. A total of 20 patients 
were enrolled and randomized into one of the treatment arms. Patients between 18-70 years of age 
with a histologically confirmed adenocarcinoma of the lower third rectum (within 5cm from anal 
verge), clinically staged as T3 and/or N1-2 using MRI, and deemed to require an APE with a curative 
intent following neoadjuvant chemoradiation were eligible to participate in this study. Patients with 
tumours involving the prostate or posterior vaginal wall that could be resected en-bloc with a sleeve 
of the prostate or posterior vagina were also included. However, patients with a locally advanced 
disease invading the pelvic walls and distant metastasis unresectable for cure were excluded. Other 
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exclusion criteria were ECOG performance status ш ? ?poor cardiopulmonary function, pregnancy, 
uncontrolled psychiatric disorders and any other contra-indication to general anaesthesia.  
While the surgeries were performed in Chennai, India, the tissue morphometric analysis was 
performed in Leeds, UK. The study was approved by the institutional ethical committee and 
registered with Clinical Trial Registry of India (CTRI no:2013/05/003661). All patients provided 
written informed consent. 
Randomisation and masking: 
Eligible patients were randomly assigned to conventional (CAPE) or extralevator (ELAPE) 
abdominoperineal excision in a 1:1 ratio using a random number table generated by a computer 
program for the proposed sample size. Randomisation was stratified according to gender. The 
random allocation sequence was generated at the Department of Epidemiology and Tumor Registry 
at our institution and the randomisation code was conveyed to the principal investigator over 
telephone. The patients and surgeons were not masked. However, the investigator performing the 
morphometric analysis was masked to the type of surgery. 
Procedures: 
Neoadjuvant chemoradiation consisted of 50.4Gy external radiation to the pelvis delivered at a rate 
of 180cGy/day for 28 days along with oral capecitabine (daily dose of 825 mg/m2). Patients were 
reassessed after 4-6 weeks by clinical examination and MRI scans. Surgery was performed 6-8 weeks 
after completion of chemoradiation. All the surgeries were performed by a single surgeon. 
In the CAPE arm, the surgery was performed in the conventional way where during the perineal 
phase, the levator muscle was cut close to the rectum on either side from below upwards removing 
only a cuff of the muscle. The perineal defect was closed primarily in two layers. 
In the ELAPE arm, the perineal phase of the surgery was performed in the prone position as 
described by Holm et al [8], following the plane outside the levator to its insertion and removing the 
muscle completely. The perineal defect was closed using a unilateral gluteus maximus 
musculocutaneous flap in the initial five cases and a fascioadipose flap in the subsequent ones.  
Photographs of the intact fresh specimen were then taken using a digital camera in the anterior, 
posterior and lateral aspects with a metric scale to allow calibration (Fig.1). Close-up views were 
taken in addition of the levators and any suspected defects or perforations. The specimen was then 
processed according to standard histopathological techniques by fixing in formalin for at least 48 
hours and then serially cross-sectioning at 5m intervals from the distal margin to the anterior 
peritoneal reflection [16]. The slices were labelled from proximal to distal and photographed 
together and individually with a metric scale and label. 
The specimens were graded according to the quality of the mesorectum (mesorectal, 
intramesorectal or intramuscular plane) and the quality of the levators/sphincters (levator, 
sphincteric or intrasphincteric plane) according to the UK LOREC guidelines [6]. Extralevator surgery 
was defined as the presence of additional levator ani muscle in the region of the lower rectum and 
anal canal with an intact external sphincter. This was confirmed by one of the authors (NPW) from 
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the specimen photographs, who was blinded to the trial arms. Conventional APE was confirmed 
ĨƌŽŵƚŚĞƐƉĞĐŝŵĞŶƉŚŽƚŽŐƌĂƉŚďǇƚŚĞƉƌĞƐĞŶĐĞŽĨĂ ?ǁĂŝƐƚ ?ĂŶĚĂďƐĞŶĐĞŽĨůĞǀĂƚŽƌĂŶŝŵƵƐĐůĞ ? 
Primary end-points: CRM status and IOP were assessed on routine histopathological examination. 
Tumor regression was graded according to the Dworak system [17]. Using specialized morphometry 
software (Aperio ImageScope, Vista, CA), the amount of tissue resected with each operation was 
determined. Specific measurements were taken in the distal 10 slices including the area outside of 
the muscularis propria/internal sphincter (MP/IS) and linear distances to the anterior, posterior and 
lateral CRMs as already described previously [3,10]. Post-operative complications were graded 
according to the Clavien-Dindo scoring system [18] at the time of discharge. All demographic, intra-
operative, post-operative, pathological and morphometric data were entered into a prospective 
database. Although the study ended at the time of discharge, the patients continue to be followed 
up as per the usual institutional protocol. 
Statistical analysis: 
Statistical analysis was performed using SPSS for Windows (version 17.0; SPSS Inc, Chicago, IL). 
Student t-test for equality of means under independent samples setting was employed to ascertain 
the statistical significance. Chi-square test for independence was used to test for the differences in 
proportions of variables measured in categorical scale. Mann Whitney U test was employed to test 
the statistical significance of variables measured in ordinal scale between the two groups. A p value 
<0 .05 was considered statistically significant. 
Results: 
Patient demographics: 
The details of the patients and the treatment are given in Table 1. Abdominoperineal excision was 
performed in 53 patients during the period of the trial of which 20 eligible patients who gave 
informed consent were randomized- 10 patients into the CAPE arm and 10 into the ELAPE arm. All 
the twenty patients completed treatment in the arm they were assigned to (Fig.2). The mean age of 
patients in the CAPE arm was lower than that of the ELAPE arm. The mean tumor size was 
significantly different higher in the CAPE arm compared to ELAPE (3.15± 0.52 vs 2.5± 0.66, p=0.03). 
Although the median duration of surgery was significantly longer in the ELAPE arm, there was a non-
significant trend towards lesser blood loss in the ELAPE arm when compared to the CAPE arm. 
Specimen grading and pathological details: 
In the ELAPE arm, the plane of dissection at the level of the sphincters was in the levator plane in all 
patients but 3 patients had a defect into the sphincters. However, in the CAPE arm, 50% of patients 
had surgery in the sphincter plane and 50% in the intrasphincteric plane. Total mesorectal excision 
was performed in the mesorectal plane in all patients in the ELAPE arm whereas in the CAPE arm, 
one patient had a dissection in the intramesorectal plane. 
The post-operative pathological staging data are given in Table 2. The mean tumour size was 
significantly larger in the CAPE arm. However, there was no significant difference in the post-
treatment T stage, N stage or number of positive lymph nodes between the two arms. Four patients 
in the ELAPE arm had a complete pathological response when compared to none in the CAPE arm. 
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The CAPE arm had a higher rate of involved CRM (40% vs 20%, p=0.32). While in the ELAPE arm the 
involved CRM was in the anterior rectal wall in one patient and lateral wall in another, in the CAPE 
arm the positive CRM was in the anterior and lateral walls in three patients and in the lateral wall in 
one patient. There were no IOPs in the ELAPE arm compared to 30% in the CAPE arm (p=0.06). All 
the perforations in the CAPE arm were in the anterior rectal wall. While 50% of CRM positive 
resections had an IOP, only 16.6% of CRM negative resections had an IOP, and conversely, an 
involved CRM was seen in 66.6% and 28.5% of patients with or without an IOP respectively. 
Tissue morphometry: 
The ELAPE procedure removed 69% more tissue outside the IS/MP in the distal ten slices of the 
resected specimen when compared to CAPE. The mean cross-sectional area of tissue removed 
outside the IS/MP in the distal ten slices overall was 1911.39 mm2 ± 382 (standard deviation [SD]) in 
the ELAPE arm compared to 1132.03 mm2 ± 371 [SD] in the CAPE arm (p<0.001). Similarly, the mean 
area of tissue removed outside the IS/MP per slice was also significantly higher after an ELAPE 
(Fig.3). We identified a significantly higher mean distance from the IS/MP to the posterior and lateral 
margins of resection in the ELAPE arm, but not to the anterior resection margin (Fig.4). The overall 
mean distance from the IS/MP to the CRM was significantly greater in the ELAPE arm (8.4mm vs 
16.2mm, p<0.0001). 
Morbidity: 
Clavien-Dindo Grade 3 complications were observed in 50% and 40% of patients undergoing ELAPE 
and CAPE respectively. These were all perineal wound related complications like wound dehiscence 
or infection requiring frequent dressings and/or debridement and secondary suturing. None of the 
patients in the ELAPE arm had loss of the perineal flap. Grade 1 and 2 complications seen included 
superficial wound infections (abdominal or perineal) that needed to be opened at the bedside or 
higher antibiotics. The median hospital stay was 13 days (range 11-32) and 17.5 days (range 14-44) 
in the CAPE and ELAPE arms respectively (p=0.08). There was no post-operative mortality in either 
arm. After a median follow-up of 30 months (range 15-44 months), there were no instances of 
perineal hernia in the ELAPE arm.  
Discussion: 
This study has demonstrated the feasibility of performing ELAPE after NCRT. We have shown that 
ELAPE in a prone position removes approximately 69% more tissue outside of the IS/MP region at 
the level of the lower rectum and anal canal than CAPE, thus enabling wider margins of resection, 
which is in line with earlier studies which reported that ELAPE removed 68%-77% more tissue in this 
region [9-11]. Tissue morphometry was first used by West et al to demonstrate that ELAPE removes 
a significantly larger amount of tissue in the distal rectum and in slices containing tumour when 
compared with standard operation using historical controls [9]. They reported that the extralevator 
procedure removed approximately 14.5 mm of extra tissue at the posterior aspect and 4mm at both 
the anterior and lateral aspects of the specimen, thereby leading to a lower rate of CRM 
involvement (14.8% v 40.6%; p=0.013). Subsequently, few other studies have also used 
morphometric analysis to compare ELAPE and CAPE (Table 3). A multicentre non-randomized study 
[10] that compared ELAPE specimens from 11 surgeons across Europe with standard APE specimens 
from a single centre in the UK also showed that the median distance from the tumour to the nearest 
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CRM was significantly greater in the ELAPE group (4·0 versus 1·5 mm; p < 0·001) leading to a 
significant reduction in the CRM involvement (49.6% vs 20.3%, p<0.001). The only randomized trial 
published so far comparing ELAPE and conventional APE showed that the median CRM distance was 
longer in the patients undergoing ELAPE (2.2 versus 1.85mm, p=0.002) resulting in fewer patients 
with positive CRM in the ELAPE group (5.7% versus 28.1%, p=0.013) [11]. We were however unable 
to demonstrate a significant reduction in the CRM positivity rates after an ELAPE although there was 
a strong trend towards it. The lack of statistical significance is likely due to the small sample size. 
While two meta-analyses have shown that the CRM involvement is significantly reduced after an 
ELAPE [20,21], two others have shown no significant difference [22,23]. As these studies have failed 
to undertake specimen photography with independent histopathological evaluation, it is not 
possible to determine the quality of either the extralevator or conventional operation. 
We found that CRM involvement was more frequent in the lateral wall when compared to the 
anterior wall in the CAPE group (four of four vs three of four positive CRMs) whereas it was equally 
distributed in the anterior and lateral walls in the ELAPE group. However, in the European 
multicentre study, the most common site of CRM involvement was the anterior wall in both ELAPE 
and conventional APE [10]. We hypothesise that this difference could be due to the fact that in our 
study, the ELAPE specimens had a significantly higher mean distance from the IS/MP to the posterior 
and lateral CRM when compared to CAPE, but not to the anterior CRM. Interestingly, we found that 
even a non-significant increase in the IS/MP to anterior CRM distance in the ELAPE arm was 
associated with a less frequent anterior CRM involvement when compared to CAPE (10% vs 30% of 
positive CRMs). A similar finding was observed in another non-randomized comparative study by 
How et al, who reported a lesser frequency of anterior CRM involvement in patients undergoing 
ELAPE in spite of a non-significant difference in the muscularis propria to margin distance in the 
anterior quadrants when compared to those undergoing CAPE [19].  
Intra-operative perforation is recognized as an important prognostic factor in rectal cancer [6]. None 
of the ELAPE specimens in the present study had an IOP compared to 30% in the CAPE specimens. 
Three meta-analyses have shown that IOP rates are significantly reduced after an ELAPE [20,22,24] 
whereas another meta-analysis showed a borderline decrease in the IOP rate after ELAPE [23]. The 
randomized trial by Han et al did not show a significant reduction in the IOP [11]. A large study from 
the Swedish colorectal cancer registry showed that although in the entire study group, the IOP rates 
were not significantly different between ELAPE and CAPE, there were significantly lower rates of 
perforations after ELAPE for tumours below 4 cm (28% vs 9%, p=0.04) [25]. The median distance of 
the lower border of the tumour from the anal verge was <2cm in both the arms of the current study. 
The anterior location of the IOP in the CAPE group as well as the absence of IOP in the ELAPE group 
could be a result of the better visualisation of the anterior dissection plane in the prone position. 
This is supported by the European multicentre study which showed that even in patients undergoing 
ELAPE, the IOP rates were significantly lower in those patients where the perineal dissection was 
done in the prone jack-knife position when compared to the lithotomy position (6.4% vs 20.6%, 
p=0.02) [10]. This clearly demonstrates that ELAPE in the prone position provides an advantage 
during the anterior perineal phase of the dissection even for surgeons who are experienced in the 
conventional procedure. Our observations regarding the association of IOP with the CRM is similar to 
that of West et al who reported that CRM involvement was significantly higher in specimens which 
had an IOP when compared to those without (70.8% vs 26.9%, p<0.0001)[9].  
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The rates of CRM and IOP are likely to be high in patients with advanced low rectal cancer, such as 
those in this series and even in other series from experienced colorectal surgeons (Table 3). 
Neoadjuvant chemoradiation can induce tumour downstaging and is therefore advocated in patients 
where the mesorectal fascia is threatened on the MRI. Rullier et al [14] reported that in cT3 rectal 
cancer patients who received NCRT, the mean CRM distance was significantly higher when the 
tumours were downstaged (10mm vs 6mm, p=0.02), suggesting that NCRT can reduce the rates of 
CRM involvement. The role of ELAPE in patients undergoing NCRT is not well defined. The proportion 
of patients receiving NCRT in published studies comparing ELAPE and APE using morphometric 
analysis ranged from 0% to 59% [9-11]. In the European multicentre study, among patients who 
received preoperative long-course chemoradiation therapy, extralevator surgery resulted in a lower 
rate of CRM involvement (12% vs 49%; p < 0.001) and IOP (6% vs 33%; p < 0.001) than conventional 
APE surgery (unpublished data). The present randomised study also suggests that ELAPE can result in 
a reduction in the frequency of CRM involvement even after NCRT.  
We observed a higher incidence of perineal wound morbidity in the ELAPE arm. Although some 
earlier reports mention that delayed perineal wound healing is significantly higher after ELAPE than 
after an APE [21,25,26], a few others report comparable perineal wound morbidity [20,22,23]. The 
uniform use of NCRT in our study would have further contributed to the delayed healing of the 
perineal wound. A recent nationwide study from Denmark reported that both the extralevator 
technique and NCRT were independent prognostic factors for long-term perineal wound 
complications [27]. The technique for perineal closure in the ELAPE arm was changed from a 
musculocutaneous flap to a fascio-adipose flap during the course of the trial since we felt that this 
would lead to less functional problems and earlier mobilisation. We did not find any difference in the 
perineal morbidity between the two techniques although the latter was easier and required less 
time. 
This study is not without its limitations. First, the small sample size makes interpretation of the 
results difficult. Second, the mean size of the tumours was significantly higher in the CAPE arm. 
Third, even though there were no significant differences in the clinical or pathological T and N stages 
between the two arms, the down-staging following NCRT was more profound in the ELAPE arm with 
a few complete pathological responders. Both these factors could have confounded the CRM 
involvement rates making interpretation of the results difficult. However, it is unlikely that the small 
difference in tumor size noticed in this study could have any clinical significance. Finally, since all 
surgeries were performed by a single surgeon, it could be argued that it lacks generalizability. 
However, we consider this to be proof of principle that a surgeon who changes his approach from 
CAPE to ELAPE could improve the oncological outcomes of the surgery with respect to CRM 
involvement and IOP. This is supported by the findings of the multicentre study, in which the CRM 
involvement reduced from 39% to 8% and the IOP from 19% to 0% among surgeons who switched 
from the conventional APE to ELAPE [10]. 
It is debatable if ELAPE has an advantage in patients who receive NCRT. Even though NCRT has an 
established and vital role in reducing CRM involvement, ELAPE has also been shown to have an 
independent effect in this regard [10]. In the European study, the CRM involvement rate was not 
different in the conventional APE group whether or not NCRT was given. However, in the ELAPE 
group, NCRT was associated with more negative CRMs (unpublished data). While NCRT can sterilise 
tumor margins, ELAPE removes more tissue around the tumor resulting in a greater distance to the 
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CRM. Thus, the two may have an additive effect in reducing CRM involvement. More importantly, 
the use of NCRT may not have influenced the rates of IOP in this study which is related more to the 
plane of surgery. Only a larger phase 3 randomised trial could answer the question of the value of 
ELAPE over CAPE in patients receiving NCRT. Assuming ELAPE reduces CRM involvement from 40% to 
20% and based on a 90% power to detect a significant difference (p<0.05, two sided), we estimate 
that nearly 220 patients would be required to be randomised between the two arms. 
Conclusion: 
We have demonstrated in this pilot study that ELAPE removes more tissue around the IS/MP of the 
lower rectum and anal canal than CAPE, which, along with an improved visualisation of the anterior 
dissection plane during the prone perineal dissection during ELAPE may translate into a lesser 
incidence of CRM involvement and IOP than CAPE.  Only an adequately powered randomised study 
can throw more light on the additional benefit of performing an ELAPE in patients who receive NCRT.  
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Table 1: Clinical and treatment details 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Standard deviation,  ?range 
CAPE- conventional abdominoperineal excision, ELAPE- extralevator abdominoperineal excision 
 
 
 
 
 
 
 
 
 
 
 
 
Variable CAPE group ELAPE group p value 
Mean age (yrs) 45.6± 11.9* 55.8± 11.7* 0.053 
Male:Female 7:3 7:3 1.0 
Mean distance 
from the anal 
verge (cm) 
1.3±0.82* 1.4±1.07* 0.87 
Mean body mass 
index (kg/m2) 
21.7± 3.4* 23± 3.3* 0.54 
No. of 
Circumferential 
tumours 
4 (40%) 5 (50%) 0.65 
Mean duration 
(minutes) 
201.5± 34.3* 294± 32.6* <0.001 
Mean blood loss 
(ml) 
340± 41.2* 205± 98.4* 0.61 
Morbidity 
(Clavien-Dindo 
score) 
  I & II 
  III  
 
 
 
6 (60%) 
4 (40%) 
 
 
 
5 (50%) 
5 (50%) 
0.47 
Median hospital 
stay (days) 
13 (11-32) ? 17.5 (14-44) 0.08 
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Table 2: Pathological outcomes 
Variable CAPE group ELAPE group p value 
Mean tumour size 
(cm) 
3.15± 0.52 2.5± 0.66 0.03 
ypT stage ? 
    ypT0 
    ypT1 
    ypT2 
    ypT3 
    ypT4 
 
0 
0 
3 
6 
1 
 
4 
1 
2 
3 
0 
0.12 
ypN stage ? 
   ypN0 
   ypN1 
   ypN2 
 
4 
4 
2 
 
8 
1 
1 
0.17 
Median no. of 
positive nodes 
(range) 
1 (0-20) 0 (0-5) 0.08 
No. of Intra-
operative 
perforation  
3 (30%) 0 (0%) 0.06 
No. of patients 
with involved 
CRM  
4 (40%) 2 (20%) 0.32 
Mean 
measurement 
from the tumour 
to the distal 
margin (cm)  
3.6± 0.65* 3.8± 1.02* 0.90 
Dworak Tumour 
regression grade 
  TRG1 
  TRG2 
  TRG3 
  TRG4 
 
 
1 
6 
3 
0 
 
 
1 
3 
2 
4 
0.15 
 
*standard deviation,  ?UICC TNM 7th edition, CAPE- conventional abdominoperineal excision ELAPE- 
extralevator abdominoperineal excision, CRM- circumferential resection margin, TRG- tumor regression grade 
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Table 3: Comparative studies of tissue morphometry 
Author 
 
No. of pts. 
ELAPE/CAPE 
Involved CRM 
ELAPE/CAPE 
Intraoperative 
perforation 
ELAPE/CAPE 
Median cross-sectional tissue 
area outside IS /MP (mm2) 
ELAPE/CAPE  
West NP9, 
2008 
27/101 15%/41%* 4%/23%* 2500/1500* 
West NP10, 
2010 
176/124 20%/49%* 8%/28%* 2120/1259* 
Han GJ11, 
2014 ? 
35/32 5.7%/28%* 5.7%/15.6% 2146/1211* 
How P19, 2014 10/10 0%/40% NA 7.7mm/5.6mm# 
Present 
study ? 
10/10 20%/40% 0%/30% 1911/1132* ? 
CRM- circumferential resection margin, IS/MP- internal sphincter/muscularis propria, ELAPE- extralevator 
abdominoperineal excision, CAPE- conventional abdominoperineal excision 
*p<0.05, #overall mean distance from IS/MP to CRM,  ?randomized controlled trial,  ?mean values 
 
 
 
Legends for figures: 
Fig.1- Photographs of a fresh unopened extralevator abdominoperineal excision specimen: a- 
anterior view, b-posterior view, c- left lateral view, d- right lateral view 
Fig.2- Trial profile 
Fig.3- Mean cross sectional tissue area outside the internal sphincter/muscularis propria in the distal 
10 slices of the specimen according to type of surgery- extralevator (ELAPE) and standard (CAPE) 
abdominoperineal excision 
Fig.4- Tissue morphometric measurements for extralevator (ELAPE) and conventional (CAPE) 
abdominoperineal excision: mean distance from the IS/MP to the anterior, posterior and lateral 
circumferential resection margin over the distal ten slices. *p<0.01 versus CAPE 
 
